#fda approval
18 stories
Ketamine: medical promise and recreational danger
The anesthetic drug approved for depression treatment is increasingly misused recreationally, raising safety concerns as its use spreads among college students.
PolitiFact · 3m
FDA approves Jaypirca for untreated blood cancers
The drug pirtobrutinib gains approval for first-time treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma in patients without a 17p deletion.
WebMD · 1m
FDA approves Atebrioz for rare bone growth disorder
The FDA has approved Atebrioz to treat fibrodysplasia ossificans progressiva, a rare genetic disease where soft tissue gradually turns to bone.
WebMD · 1m
FDA approves Rhapsido for hives from skin rubbing
The FDA has approved Rhapsido for symptomatic dermographism, a condition where skin rubbing triggers severe itching and hives in adults whose symptoms don't respond to standard allergy medicines.
WebMD · 1m
Efferon's device targets pediatric sepsis
A startup selected for TechCrunch Disrupt 2026 has developed a blood purification device designed to save children from sepsis, a leading cause of childhood death.
TechCrunch · 1m
New weight-loss drugs promise fewer side effects
Amylin-based medications show promise as alternatives to GLP-1 drugs, causing less nausea and stomach trouble while delivering comparable weight loss.
TIME · 2m
Women seek testosterone for low sex drive as doctors face treatment gaps
Women increasingly use testosterone for menopause symptoms but face insurance barriers and dosing challenges.
Fox News · 1m
Eli Lilly's weight-loss drug shows strong results
An experimental drug from Eli Lilly called retatrutide produced significant weight loss in two new studies, outperforming existing medications.
TIME · 2m
Eli Lilly's $1500 Target Surprises Wall Street
Eli Lilly's revenue growth outpaces stock price, with analysts missing a $1500 target by 2027
24/7 Wall St. · 1m
Revolution Medicines' Pancreatic Cancer Drug Shows Breakthrough Results
Revolution Medicines' new pancreatic cancer drug shows strong clinical results, signaling potential shift in cancer treatment approaches
Yahoo Finance · 1m
Eight Sleep's Pod 6 shrinks to fit more beds
The sleep tech company launches a smaller, cheaper smart mattress pad that works with more bed frames and comes in solo sizes.
TechCrunch · 1m
Can Zenas BioPharma justify its $108M quarterly burn?
A clinical-stage biotech with $673.9M in cash races toward an FDA decision that will make or break its future.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 2m
CDC finally opens COVID vaccine orders after month-long delay
States can now order free COVID-19 vaccines for children, but Trump officials have not explained why ordering was held up for nearly a month.
Ars Technica · 1m
Before You Book Online Weight or Hormone Care
Online clinics offer real oversight, but they're not all equal. Here's what to verify before paying.
Wellbeing Magazine · 3m
New blood tests can spot Alzheimer's earlier than ever
Four FDA-cleared blood tests now detect Alzheimer's disease before symptoms appear, but doctors warn they're not for everyone.
TIME · 3m
Male birth control is finally becoming real
After 50 years of false starts, new contraceptives for men are entering late-stage trials and could hit the market by 2030.
Mother Jones · 3m
Alzheimer's research is finally making real progress
After decades of stalled research, scientists now have new drugs and multiple treatment approaches that offer hope for slowing cognitive decline.
Vox · 3m
What to know before starting GLP-1 weight loss drugs
These medications do more than help you lose weight, but they're not right for everyone.
Valleynewslive · 1m